These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 31829262

  • 21. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J, van der Pol S, Nijland P, Amor S, Perron H.
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [Abstract] [Full Text] [Related]

  • 22. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
    Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, Schmidbauer M, Parisi JE, Lassmann H.
    Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
    [Abstract] [Full Text] [Related]

  • 23. Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role.
    Waller R, Woodroofe MN, Wharton SB, Ince PG, Francese S, Heath PR, Cudzich-Madry A, Thomas RH, Rounding N, Sharrack B, Simpson JE.
    J Neuroimmunol; 2016 Oct 15; 299():139-146. PubMed ID: 27725112
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of the ubiquitin-editing enzyme A20 in the brain lesions of Multiple Sclerosis patients: moving from systemic to central nervous system inflammation.
    Perga S, Montarolo F, Martire S, Bonaldo B, Bono G, Bertolo J, Magliozzi R, Bertolotto A.
    Brain Pathol; 2021 Mar 15; 31(2):283-296. PubMed ID: 33051914
    [Abstract] [Full Text] [Related]

  • 25. Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.
    Chomyk A, Kucinski R, Kim J, Christie E, Cyncynatus K, Gossman Z, Chen Z, Richardson B, Cameron M, Turner T, Dutta R, Trapp B.
    Ann Neurol; 2024 May 15; 95(5):907-916. PubMed ID: 38345145
    [Abstract] [Full Text] [Related]

  • 26. Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study.
    Margoni M, Petracca M, Schiavi S, Fabian M, Miller A, Lublin FD, Inglese M.
    Eur J Neurol; 2019 Aug 15; 26(8):1068-1074. PubMed ID: 30761708
    [Abstract] [Full Text] [Related]

  • 27. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL.
    Brain; 2019 Sep 01; 142(9):2787-2799. PubMed ID: 31497864
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.
    Lindberg RL, De Groot CJ, Certa U, Ravid R, Hoffmann F, Kappos L, Leppert D.
    J Neuroimmunol; 2004 Jul 01; 152(1-2):154-67. PubMed ID: 15223248
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis.
    Zeis T, Howell OW, Reynolds R, Schaeren-Wiemers N.
    Exp Neurol; 2018 Jul 01; 305():76-88. PubMed ID: 29596844
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas.
    Park E, Gallezot JD, Delgadillo A, Liu S, Planeta B, Lin SF, O'Connor KC, Lim K, Lee JY, Chastre A, Chen MK, Seneca N, Leppert D, Huang Y, Carson RE, Pelletier D.
    Eur J Nucl Med Mol Imaging; 2015 Jun 01; 42(7):1081-92. PubMed ID: 25833352
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of Bruton´s tyrosine kinase in different type of brain lesions of multiple sclerosis patients and during experimental demyelination.
    Elkjaer ML, Waede MR, Kingo C, Damsbo K, Illes Z.
    Front Immunol; 2023 Jun 01; 14():1264128. PubMed ID: 38022591
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.